Incyte Corp (INCY)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$94.01

Buy

$96.33

arrow-down$-0.69 (-0.72%)

Prices updated at 13 Dec 2025, 00:52 EST

Prices minimum 15 mins delay

Prices in USD

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$96.00 - $93.54
	$109.28 - $53.56
	-
	18,731.15m
	16.17
	-
	2,264,451
	4.03
	1,953,625.62
	1.02
	193.43m
	US45337C1027
	5.90
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.